Clinical Trials Logo

Lung Diseases clinical trials

View clinical trials related to Lung Diseases.

Filter by:

NCT ID: NCT05979454 Recruiting - Clinical trials for Rheumatoid Arthritis-Associated Interstitial Lung Disease

Value of KL-6 in Rheumatoid Arthritis-Associated ILD

Start date: January 1, 2023
Phase:
Study type: Observational

Evaluation of serum KL6 level in rheumatoid arthritis-associated interstitial lung disease (RA-ILD).

NCT ID: NCT05972122 Recruiting - Lung Diseases Clinical Trials

Serratus Posterior Superior Interfascial Plane Block for Thoracoscopic Surgery

Start date: August 9, 2023
Phase: N/A
Study type: Interventional

Regional techniques can be used for postoperative pain control following VATS. Ultrasound (US) guided serratus posterior superior block (SPSPB) is a new interfacial plane block defined by Tulgar et al in 2023. It is based on injection on the serratus posterior superior muscle at the level of the 2nd or 3rd rib. This block provides analgesia in conditions such as interscapular pain, chronic myofascial pain syndromes, scapulocostal syndrome, and shoulder pain. The SPS muscle is located at the C7-T2 level. It attaches to the lateral edges of the second and fifth ribs. It is innervated by the lower cervical and upper intercostal nerves. With the SPS block, these nerves are blocked and analgesia is provided.

NCT ID: NCT05967117 Recruiting - Pulmonary Disease Clinical Trials

Chest CT Using Low-concentration Iodine Contrast Media

Start date: November 24, 2023
Phase: Phase 4
Study type: Interventional

This study aims to evaluate the quality of images when low-concentration iodine contrast agents is used in chest CT with low tube voltage and if they can be used in routine imaging. The primary endpoint of the study was the quality of the image and comparison of chest CT by using low and conventional concentration iodine contrast agents with low tube voltage and chest CT by using the conventional concentration iodine contrast agents with the conventional tube voltage; The secondary endpoint is optimizing chest CT protocol using an iodine contrast agent.

NCT ID: NCT05964491 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Video Resources for People With Chronic Obstructive Pulmonary Disease: An Exploratory Qualitative Study

Start date: October 20, 2022
Phase:
Study type: Observational

The IPCRG & Teesside University have searched the internet for video self management content for people living with COPD. Resources were reviewed by healthcare professionals and developed into a digital magazine to support people living with chronic obstructive Pulmonary Disease (COPD). The aims of this study are to 1. evaluate the use of the digital magazine format with video self-management content from an end user perspective, including 1. what characteristics a good video resource should have 2. what information is important to people with COPD to include in videos and digital magazines, 3. the useability of a digital magazine format 2. Explore the opinions, experiences and preferences of people living with COPD for accessing online self-management content including barriers and facilitators for accessing online self-management video content

NCT ID: NCT05948904 Recruiting - Lung Diseases Clinical Trials

Defining a Technique for the Use of Cryogenic Catheters for Biopsy and Ablation for the Diagnostic and Treatment of Pulmonary Lesions: An Ex-Vivo Human Lung Model Study.

CT0129
Start date: November 3, 2023
Phase: N/A
Study type: Interventional

Developing a standardized methodology for the use of novel cryogenic catheters for transbronchial cryobiopsy and cryoablation of pulmonary lesions.

NCT ID: NCT05948891 Recruiting - COPD Clinical Trials

Impact of Fixed TRIple Therapy With Beclometasone/Formoterol/Glycopyrronium DPI (Trimbow® in NEXThaler Device) in Chronic Obstructive PulmoNary Disease in rEal-world Settings: Health-related Quality of Life Patient' eXpectations and characterisTics: the TriNEXT Study

TriNEXT
Start date: August 1, 2023
Phase:
Study type: Observational

This is an observational, prospective, multicentric, cohort study conducted in France to evaluate the QoL in COPD patients treated with TRIMBOW NEXThaler 88/5/9 in a routine clinical practice setting. Patients enrolled in this study will be patients diagnosed with a COPD with a ratio of post-bronchodilator (salbutamol 400 μg) forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) of less than 0.7 to whom TRIMBOW NEXThaler 88/5/9 has been initiated by an hospital or local pulmonologists in accordance with clinical practice and marketing authorization.

NCT ID: NCT05943535 Recruiting - Clinical trials for Interstitial Lung Disease

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Start date: October 30, 2023
Phase: Phase 3
Study type: Interventional

Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.

NCT ID: NCT05940480 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

TCM Daoyin Therapy in Individuals At-risk for COPD

Start date: January 3, 2023
Phase: N/A
Study type: Interventional

Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable disease. The aim of prospective randomized study is to evaluate the effects of TCM Daoyin training on Individuals at-risk for COPD.

NCT ID: NCT05939999 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Effects of Elastic Tape on Pulmonary Rehabilitation of Patients With Chronic Obstructive Pulmonary Disease

ETReaCOPD
Start date: October 26, 2023
Phase: N/A
Study type: Interventional

Evaluate the effect of the use of elastic tape in chest wall and abdomen in the physical capacity, psychosocial distress levels, quality of life and anxiety, and depression symptoms of individuals with moderate to very severe chronic obstructive pulmonary disease (COPD) undergoing pulmonary rehabilitation.

NCT ID: NCT05937191 Recruiting - Clinical trials for Idiopathic Pulmonary Hemosiderosis

Leflunomide for Idiopathic Pulmonary Hemosiderosis in Children

Lef for IPH
Start date: June 1, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The goal of this clinical trial is to compare Leflunomide in Idiopathic pulmonary hemosiderosis. The main questions it aims to answer are: - The efficacy and safety of Leflunomide in Idiopathic pulmonary hemosiderosis - The mechanism of leflunomide in treating Idiopathic pulmonary hemosiderosis Participants will be treated with leflunomide plus stroid. A comparison group: Researchers will compare the control group treated with stroid to see if the efficacy of Leflunomide would be better than control group.